[go: up one dir, main page]

AU2003216382A1 - Idothyronine compositions - Google Patents

Idothyronine compositions

Info

Publication number
AU2003216382A1
AU2003216382A1 AU2003216382A AU2003216382A AU2003216382A1 AU 2003216382 A1 AU2003216382 A1 AU 2003216382A1 AU 2003216382 A AU2003216382 A AU 2003216382A AU 2003216382 A AU2003216382 A AU 2003216382A AU 2003216382 A1 AU2003216382 A1 AU 2003216382A1
Authority
AU
Australia
Prior art keywords
idothyronine
compositions
idothyronine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003216382A
Other languages
English (en)
Other versions
AU2003216382A8 (en
Inventor
Randal J. Kirk
Lawrence P. Olon
Thomas Piccariello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New River Pharmaceuticals Inc
Original Assignee
New River Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/136,433 external-priority patent/US7163918B2/en
Priority claimed from US10/156,527 external-priority patent/US7060708B2/en
Application filed by New River Pharmaceuticals Inc filed Critical New River Pharmaceuticals Inc
Publication of AU2003216382A1 publication Critical patent/AU2003216382A1/en
Publication of AU2003216382A8 publication Critical patent/AU2003216382A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003216382A 2002-02-22 2003-02-24 Idothyronine compositions Abandoned AU2003216382A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US35838102P 2002-02-22 2002-02-22
US60/358,381 2002-02-22
US36625802P 2002-03-22 2002-03-22
US60/366,258 2002-03-22
US10/136,433 US7163918B2 (en) 2000-08-22 2002-05-02 Iodothyronine compositions
US10/136,433 2002-05-02
US10/156,527 2002-05-29
US10/156,527 US7060708B2 (en) 1999-03-10 2002-05-29 Active agent delivery systems and methods for protecting and administering active agents
PCT/US2003/005526 WO2003072047A2 (fr) 2002-02-22 2003-02-24 Compositions d'iodothyronine

Publications (2)

Publication Number Publication Date
AU2003216382A1 true AU2003216382A1 (en) 2003-09-09
AU2003216382A8 AU2003216382A8 (en) 2003-09-09

Family

ID=27767913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003216382A Abandoned AU2003216382A1 (en) 2002-02-22 2003-02-24 Idothyronine compositions

Country Status (2)

Country Link
AU (1) AU2003216382A1 (fr)
WO (1) WO2003072047A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050010756A (ko) * 2002-02-22 2005-01-28 뉴 리버 파마슈티칼스, 인크. 피험자 간 약물 혈청 농도의 변동성을 감소시키기 위한펩티드-약물 접합체의 용도
EP2316469A1 (fr) * 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
CN107561168A (zh) * 2016-06-30 2018-01-09 山东新时代药业有限公司 一种聚乙二醇化促胰岛素分泌肽类似物的分析检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489165A (en) * 1983-01-24 1984-12-18 Becton Dickinson And Company Chromogenic tracers for use in an assay
US4719182A (en) * 1985-03-18 1988-01-12 Eastman Kodak Company Fluorescent labels and labeled species and their use in analytical elements and determinations
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
US5352803A (en) * 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
CA2157767A1 (fr) * 1993-03-09 1994-09-15 Elaine M. Brate Enzymes concues genetiquement et leurs conjugues pour essais diagnostiques
US6342225B1 (en) * 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US5910569A (en) * 1994-11-22 1999-06-08 Lotus Biochemical Corporation Iodothyronine polymers
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine

Also Published As

Publication number Publication date
WO2003072047A3 (fr) 2004-06-17
WO2003072047A2 (fr) 2003-09-04
AU2003216382A8 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
AU2003219116A1 (en) Fragrance compositions
AU2003285288A1 (en) Composition
AU2003279340A1 (en) Shampoo compositions
AU2003239690A1 (en) Jettable compositions
AU2003254863A1 (en) Herbicide compositions
AU2003240963A1 (en) Cleaning compositions
AU2003224597A1 (en) Organic compositions
AU2003247629A1 (en) Wet-developable anti-reflective compositions
AU2003259290A1 (en) Glass compositions
AU2003301654A1 (en) Stabilized composition
AU2003202265A1 (en) Fungicide compositions
AU2003300056A1 (en) Organic compositions
AU2002950744A0 (en) Composition
AU2003256805A1 (en) Compounds compositions and methods
AU2003218121A1 (en) Lotion compositions
AU2003201595A1 (en) Fragrance compositions
AU2003235708A1 (en) Polytartrate composition
AU2003302305A1 (en) Benzoquinolizine-2-carboxylic acid-containing compositions
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2002358764A1 (en) Antiperspirant compositions
AU2003217110A1 (en) Novel formulation
AU2003269177A1 (en) Antimicrobial compositions
AU2003293621A1 (en) Liposome-forming compositions
AU2003301902A1 (en) Cosmetic compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase